Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia
- PMID: 26593076
- PMCID: PMC4662054
- DOI: 10.1016/j.clp.2015.08.004
Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia
Abstract
The pathogenesis of bronchopulmonary dysplasia (BPD) is multifactorial, and the clinical phenotype of BPD is extremely variable. Several clinical and laboratory biomarkers have been proposed for the early identification of infants at higher risk of BPD and for determination of prognosis of infants with a diagnosis of BPD. The authors review available literature on prediction tools and biomarkers of BPD, using clinical variables and biomarkers based on imaging, lung function measures, and measurements of various analytes in different body fluids that have been determined to be associated with BPD either in a targeted manner or by unbiased omic profiling.
Keywords: Biomarkers; Bronchopulmonary dysplasia; Early diagnosis; Infant; Premature; Prognosis; Pulmonary hypertension; Systems biology.
Copyright © 2015 Elsevier Inc. All rights reserved.
References
-
- Walsh MC, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004 Nov;114(5):1305–1311. - PubMed
-
- Northway WH, Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967 Feb 16;276(7):357–368. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
